A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...
Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission ...
Acute pancreatitis is a common and costly gastrointestinal condition with significant risk of complications. The 2024 ...
While negative experiences during early life are known to disrupt gut-brain axis development, the mechanisms linking ...
Fish bone is a household health hazard and yet awareness about their risks remain low. Most families assume that if there's ...
A rough morning after a night of drinking often sends people straight to the medicine cabinet, reaching for ibuprofen to ...
Sobi (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza (olezarsen) reduced the relative ...
Opinion

Need to invest in dengue treatment

This article is authored by Sanjay Sarin and G Karthikeyan.
Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF® (+27%) and APONVIE® (+50%)Q1 2026 total net ...
Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio –– Extends ...